Clinical Trial Update: Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of VGR-R01 gene therapy for Bietti Crystalline Dystrophy; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bietti Crystalline Dystrophy
• Inherited Retinal Diseases

Drugs mentioned

• VGR-R01

Snippet

Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. | Conditions: Bietti Crystalline Dystrophy, Inherited Retinal Diseases | Phase 3 | Status: ACTIVE_NOT_RECRUITING